Detalhe da pesquisa
1.
Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies.
COPD;
13(1): 1-10, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26451734
2.
Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
Pulm Pharmacol Ther;
31: 85-91, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25197005
3.
Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial.
BMC Pulm Med;
15: 91, 2015 Aug 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26286141
4.
Umeclidinium in patients with COPD: a randomised, placebo-controlled study.
Eur Respir J;
43(1): 72-81, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23949963
5.
Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study.
Respir Res;
15: 78, 2014 Jul 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25015176
6.
Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study.
BMC Pulm Med;
14: 2, 2014 Jan 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24393134
7.
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.
Lancet Microbe;
4(11): e863-e874, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37783221
8.
Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study.
Int J Chron Obstruct Pulmon Dis;
12: 745-755, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28280319
9.
Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials.
Respir Med;
112: 65-74, 2016 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26797016
10.
A randomised, open-label study of umeclidinium versus glycopyrronium in patients with COPD.
ERJ Open Res;
2(2)2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27730198
11.
A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 µg on health-related quality of life in patients with COPD.
Int J Chron Obstruct Pulmon Dis;
11: 971-9, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27274218
12.
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD.
Int J Chron Obstruct Pulmon Dis;
11: 719-30, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27103795
13.
Genetic effects on treatment response of umeclidinium/vilanterol in chronic obstructive pulmonary disease.
Respir Med;
114: 123-6, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27109822
14.
The effect of umeclidinium added to inhaled corticosteroid/long-acting ß2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.
NPJ Prim Care Respir Med;
26: 16031, 2016 06 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27334739
15.
Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
Int J Chron Obstruct Pulmon Dis;
11: 1873-80, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27578968
16.
Mast cell desensitization inhibits calcium flux and aberrantly remodels actin.
J Clin Invest;
126(11): 4103-4118, 2016 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27669462
17.
Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study.
Int J Chron Obstruct Pulmon Dis;
10: 1753-67, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26366068
18.
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies.
Respir Med;
109(9): 1155-63, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26117292
19.
Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations.
Respir Med;
109(7): 870-81, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26006754
20.
Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis.
Immunol Lett;
90(1): 59-64, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14611909